+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration



Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration



Veterinary Clinical Pathology 44(3): 420-430



The N-terminal fragment of the prohormone B-type natriuretic peptide (NT-proBNP) and cardiac troponin-I are candidate biomarkers for cardiac disease in dogs. The degree of biologic variation in these biomarkers has not previously been reported in healthy dogs or dogs with mitral regurgitation. The purpose of the study was to derive estimates of intrinsic biologic variability and reference change values for NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral regurgitation grade IB and II according to the International Small Animal Cardiac Health Council (ISACHC) grading system. Plasma and sera were collected weekly for up to 7 weeks from 12 control dogs and 9 dogs with mitral regurgitation. NT-proBNP and troponin-I (C-TnI) concentrations were determined. Indices of biologic variation such as reciprocal index of individuality (r-IoI) and reference change values (RCV) were calculated in both the groups. Individuality was high in control dogs and dogs with grade IB and II mitral valve regurgitation for both C-TnI (r-IoI 1.6 and 2) and NT-proBNP (1.5 and 2.7), while the 2-sided RCV for NT-proBNP was significantly lower in dogs with mitral regurgitation (52.5% vs 99.4%, P<0.01.). High individuality of these cardiac biomarkers suggests that, following diagnosis, these assays are best interpreted by serial determination in individual canine patients rather than by comparison to a population-based reference interval. The smaller RCV values for dogs with mitral regurgitation suggest that smaller relative changes in NT-proBNP are clinically meaningful in these patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 057304696

Download citation: RISBibTeXText

PMID: 26108974

DOI: 10.1111/vcp.12268


Related references

Biologic variability of cardiac troponin I in healthy dogs and dogs with different stages of myxomatous mitral valve disease using standard and high-sensitivity immunoassays. Veterinary Clinical Pathology 46(2): 299-307, 2017

Biologic variability of N-terminal pro-brain natriuretic peptide in healthy dogs and dogs with myxomatous mitral valve disease. Journal of Veterinary Cardiology 19(2): 124-131, 2017

Serum concentrations of cardiac troponin I and cardiac troponin T in dogs with class IV congestive heart failure due to mitral valve disease. Journal of Veterinary Emergency and Critical Care 17(3): 243-249, 2007

Mitral valve morphology assessed by three-dimensional transthoracic echocardiography in healthy dogs and dogs with myxomatous mitral valve disease. Journal of Veterinary Cardiology 19(2): 113-123, 2017

Echocardiographic anatomy of the mitral valve in healthy dogs and dogs with myxomatous mitral valve disease. Journal of Veterinary Cardiology 17(2): 97-106, 2016

Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs. Journal of Veterinary Internal Medicine 24(1): 153-159, 2010

Sildenafil improves heart rate variability in dogs with asymptomatic myxomatous mitral valve degeneration. Journal of Veterinary Medical Science 79(9): 1480-1488, 2017

Serial analysis of serum cardiac troponin I changes and correlation with clinical findings in 46 dogs with mitral valve disease. Veterinary Clinical Pathology 43(2): 218-225, 2015

Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease. Journal of Veterinary Internal Medicine 27(3): 500-506, 2013

Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease. Journal of Veterinary Cardiology 16(3): 155-162, 2015

Left atrial size and contractile function in healthy dogs and dogs with chronic mitral valve disease. Pesquisa Veterinaria Brasileira 38(8): 1622-1630, 2018

Correlation of serum cardiac troponin I and acute phase protein concentrations with clinical staging in dogs with degenerative mitral valve disease. Veterinary Clinical Pathology 44(3): 397-404, 2016

Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease. Journal of Veterinary Cardiology 19(6): 469-479, 2017

Assessment of Left Atrial Deformation and Function by 2-Dimensional Speckle Tracking Echocardiography in Healthy Dogs and Dogs With Myxomatous Mitral Valve Disease. Journal of Veterinary Internal Medicine 31(3): 641-649, 2017

The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease. Journal of Veterinary Internal Medicine 26(2): 302-311, 2012